Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash Provided by (Used in) Operating Activities
Net earnings (losses)	$ 516	$ 5,716
Adjustments to reconcile net earnings (losses) to operating cash flows:
Depreciation and amortization	163	168
Deferred income tax provision (benefit)	(261)	215
Earnings from equity investments	(866)	(759)
Dividends from ABI	221	477
Loss on ABI/SABMiller business combination	0	33
Loss on Cronos-related financial instruments	1,327	0
Impairment of JUUL equity securities	4,500	0
Asset impairment and exit costs, net of cash paid	(33)	(24)
Cash effects of changes:
Receivables	(21)	(45)
Inventories	147	147
Accounts payable	(157)	(79)
Income taxes	174	308
Accrued liabilities and other current assets	(359)	(319)
Accrued settlement charges	(360)	757
Pension plan contributions	(51)	(19)
Pension provisions and postretirement, net	(42)	(19)
Other, net	376	9
Net cash provided by (used in) operating activities	5,274	6,566
Cash Provided by (Used in) Investing Activities
Capital expenditures	(160)	(132)
Investment in Cronos	(1,863)	0
Acquisition of businesses and assets	(421)	(15)
Other, net	32	10
Net cash provided by (used in) investing activities	(2,412)	(137)
Cash Provided by (Used in) Financing Activities
Repayment of short-term borrowings	(12,800)	0
Long-term debt issued	16,265	0
Long-term debt repaid	(1,144)	0
Repurchases of common stock	(346)	(1,317)
Dividends paid on common stock	(4,498)	(3,909)
Other, net	(127)	(25)
Net cash provided by (used in) financing activities	(2,650)	(5,251)
Cash, cash equivalents and restricted cash:
Increase (decrease)	212	1,178
Balance at beginning of period	1,433	1,314
Balance at end of period	1,645	2,492
Cash, cash equivalents and restricted cash	$ 1,645	$ 1,314